The Enterprise Value as of December 2025 (TTM) for Sera Prognostics, Inc. (SERA) is 112.73M

According to Sera Prognostics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 112.73M. This represents a change of -35.95% compared to the average of 176.00M of the last 4 quarters.

Sera Prognostics, Inc. (SERA) Historical Enterprise Value (quarterly & annually)

How has SERA Enterprise Value performed in the past?

The mean historical Enterprise Value of Sera Prognostics, Inc. over the last ten years is 171.64M. The current 112.73M Enterprise Value has changed 6.47% with respect to the historical average. Over the past ten years (40 quarters), SERA's Enterprise Value was at its highest in in the March 2021 quarter at 304.27M. The Enterprise Value was at its lowest in in the June 2022 quarter at -1537189.76.

Sera Prognostics, Inc. (SERA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sera Prognostics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sera Prognostics, Inc. (SERA) Average Enterprise Value

How has SERA Enterprise Value performed in the past?

The current Enterprise Value of Sera Prognostics, Inc. (SERA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sera Prognostics, Inc. (SERA) Enterprise Value vs. Peers

How is SERA’s Enterprise Value compared to its peers?

Sera Prognostics, Inc.’s Enterprise Value is less than Rapid Micro Biosystems, Inc. (180.31M), greater than Sharps Technology, Inc. (63.85M), greater than Tevogen Bio Holdings Inc. (87.23M), less than Cognition Therapeutics, Inc. (115.88M), greater than Atossa Therapeutics, Inc. (41.60M), greater than Lucid Diagnostics Inc. (105.50M), less than Apyx Medical Corporation (134.79M), greater than Surrozen, Inc. (76.12M), greater than TuHURA Biosciences, Inc. (94.60M), less than Oncolytics Biotech Inc. (123.79M),

Build a custom stock screener for Sera Prognostics, Inc. (SERA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sera Prognostics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sera Prognostics, Inc. (SERA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sera Prognostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.